Rikkunshi-TO


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 25.6%
Chronic Hepatitis C 10.5%
Pneumonia 10.5%
Emphysema 9.3%
Decreased Appetite 8.1%
Hyperuricaemia 5.8%
Adverse Event 4.7%
Benign Prostatic Hyperplasia 4.7%
Dyspepsia 4.7%
Hypertension 4.7%
Sinus Arrhythmia 4.7%
Prophylaxis 2.3%
Skin Disorder 2.3%
Adverse Reaction 1.2%
Gastrointestinal Disorder 1.2%
Interstitial Lung Disease 62.5%
Platelet Count Decreased 12.5%
Renal Impairment 12.5%
White Blood Cell Count Decreased 12.5%
Concomitant
Prophylaxis 13.1%
Hypertension 8.7%
Hepatitis C 8.6%
Chronic Hepatitis C 8.4%
Product Used For Unknown Indication 7.6%
Asthma 6.3%
Insomnia 6.3%
Constipation 5.1%
Somatoform Disorder 4.9%
Gastritis 4.2%
Depression 4.1%
Rheumatoid Arthritis 3.6%
Gastritis Prophylaxis 3.1%
Pain 2.8%
Decreased Appetite 2.6%
Abdominal Pain 2.4%
Fluid Replacement 2.4%
Gastric Ulcer 2.1%
Type 2 Diabetes Mellitus 2.0%
Drug Use For Unknown Indication 1.8%
Dysuria 10.1%
Retinopathy 10.1%
Renal Impairment 7.9%
White Blood Cell Count Decreased 7.9%
Nausea 6.7%
Upper Gastrointestinal Haemorrhage 6.7%
Wrong Technique In Drug Usage Process 6.7%
Off Label Use 4.5%
Palmar-plantar Erythrodysaesthesia Syndrome 4.5%
Parkinsonism 4.5%
Anaemia 3.4%
Death 3.4%
Drug Eruption 3.4%
Fall 3.4%
Platelet Count Decreased 3.4%
Stomatitis 3.4%
Ventricular Extrasystoles 3.4%
Atrial Fibrillation 2.2%
Blood Creatinine Increased 2.2%
Blood Potassium Increased 2.2%

Drug Data